Latest Updates
-
Arijit Singh India Tour 2027: First Concerts After Playback Exit -
Healthy Navratri Recipes: 8 Low-Oil Vrat Dishes To Try This Year -
Harmanpreet Kaur Steps Down As Captain: Career In Numbers And Mandhana Likely Next -
Why Stress Can Make Psoriasis Flare And Why Scratching Makes It Worse -
Jeffrey Archer Dies At 86, One Day Before Adam & Eve Goes On Sale -
Amitabh Bachchan, 83, Struggles To Sleep After Knee Injury On KBC 18 -
World Cerebral Palsy Day 2026: Theme, Significance And Why Inclusion Matters For People With CP In India -
Navratri 2026: 5 Vrat Recipes To Add A Fresh Twist To Your Traditional Fasting Food Menu -
Navratri Recipes 2026: Quick Navratri Recipes You Can Make In Under 30 Minutes -
Handwoven Craft Meets Contemporary Elegance In Kasturi Kundal’s Festive Edit
Compound That Can Potentially Ease COVID-19 Symptoms Identified
Scientists have identified a compound that shows potential in easing the symptoms of COVID-19 infection in laboratories and animals.

The team, from the US Department of Energy's Pacific Northwest National Laboratory (PNNL) and the University of North Carolina (UNC), studied the virus that causes Middle East Respiratory Syndrome, which is caused by a coronavirus.
MERS is much less common, but much more lethal, than COVID-19.
The study, published in the journal mBio, analysed tens of thousands of measurements in the laboratory of proteins, molecular messengers and other signals that occur after infection.
The researchers pinpointed a molecular process, part of the body's quality-control machinery, that plays a central role in causing damage from a coronavirus infection.
They then searched a vast database of compounds and identified one known as AMG PERK 44 that put a halt to virus reproduction in human tissue in the laboratory.
The team also found the compound has a strong effect in mice infected with the virus. The compound boosted lung function and reduced lung damage and weight loss in the mice, particularly in male mice, according to the researchers.
"Studies like this help us learn more about how deadly respiratory viruses operate, how they do what they do, why they attack certain parts of the lung and not others," said virologist Amy Sims, one of two first coauthors of the paper from PNNL, along with Hugh Mitchell.
The scientists noted that it is far too soon to know whether the compound could help patients as it is not currently used as a drug. The results of the study are most useful as part of a broader effort to learn more about respiratory diseases, they added.
"Coronavirus infections cause complex disease phenotypes, and new strategies are needed to disentangle which host pathways are contributing to the development of severe, life-threatening outcomes," Ralph Baric from UNC added.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
